Chatham Capital Group Inc. Trims Holdings in Abbott Laboratories (NYSE:ABT)
Chatham Capital Group Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 45.3% in the 3rd quarter, Holdings Channel reports. The firm owned 9,002 shares of the healthcare product maker’s stock after selling 7,465 shares during the quarter. Chatham Capital Group Inc.’s holdings in Abbott Laboratories were worth $872,000 at the end […]